<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382612</url>
  </required_header>
  <id_info>
    <org_study_id>2018-22</org_study_id>
    <nct_id>NCT04382612</nct_id>
  </id_info>
  <brief_title>Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.</brief_title>
  <acronym>ASCEND</acronym>
  <official_title>Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the long-term safety and performance of the HARPOON™ MVRS for use in patients&#xD;
      presenting with severe degenerative mitral regurgitation due to posterior leaflet prolapse in&#xD;
      the post-market phase.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a single arm, prospective, multi-center, non-randomized and open-label&#xD;
      post-market study that will evaluate subjects for up to 5 years post treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2020</start_date>
  <completion_date type="Anticipated">June 2027</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subject's With Freedom from all-cause mortality, disabling stroke and life-threatening bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>Subject's freedom from all-cause mortality, disabling stroke and life- threatening bleeding at 30 days post-implant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With Procedural Success During the First 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Subject's procedural success at 30 days post-treatment, as measured by: Technical success with reduction of MR to less than or equal to mild and the absence of major device or procedure-related SAEs.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>HARPOON MVRS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects who were treated with the HARPOON MVRS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HARPOON Beating Heart Mitral Valve Repair System (MVRS)</intervention_name>
    <description>Repair of the chordae tendinae in the mitral valve.</description>
    <arm_group_label>HARPOON MVRS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is &gt; 18 years old&#xD;
&#xD;
          2. Presence of severe MR as read on a transthoracic echocardiographic study&#xD;
&#xD;
          3. Mitral leaflet coaptation surface is sufficient to reduce mitral regurgitation without&#xD;
             undue leaflet tension (approximate leaflet to gap ratio of 2:1) based on the judgment&#xD;
             of the patient eligibility committee and the operating surgeon&#xD;
&#xD;
          4. Degenerative mitral valve disease with mid-segment P2 prolapse&#xD;
&#xD;
          5. Patient is able to sign informed consent and able to return for follow-up and is&#xD;
             capable of participating in all testing associated with this clinical investigation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient is of the age where further growth is expected&#xD;
&#xD;
          2. Active endocarditis&#xD;
&#xD;
          3. Left ventricular or left atrial appendage thrombus&#xD;
&#xD;
          4. Severe mitral annular and/or leaflet calcification&#xD;
&#xD;
          5. Cannot tolerate procedural anticoagulation or post-procedure antiplatelet regimen&#xD;
&#xD;
          6. Mitral stenosis&#xD;
&#xD;
          7. Functional Mitral Valve disease&#xD;
&#xD;
          8. Previous mitral valve replacement surgery&#xD;
&#xD;
          9. Fragile or thinning apex&#xD;
&#xD;
         10. Contraindications to transoesophageal echocardiography (atlantoaxial disease, severe&#xD;
             generalized cervical arthritis, upper gastrointestinal bleeding, significant dysphagia&#xD;
             and odynophagia, has received extensive radiation to the mediastinum)&#xD;
&#xD;
         11. Patient is pregnant or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Walther, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Payam Akhyari, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heine University Dusseldorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabrina Hundt</last_name>
    <phone>949-250-2500</phone>
    <email>Sabrina_Hundt@edwards.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marieke Vijge</last_name>
    <phone>949-250-2500</phone>
    <email>Marieke_Vijge@edwards.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kepler Universitätsklinikum GmbH</name>
      <address>
        <city>Linz</city>
        <state>Oberösterreich</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andreas Zierer, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck, Universitätsklinik für Herzchirurgie</name>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nikolaos Bonaros, Assoz Prof Priv-Doz Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Württemberg</state>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andreas Liebold, Prof Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhön Klinikum Kardiochirurgie</name>
      <address>
        <city>Bad Neustadt</city>
        <state>Bayern</state>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arno Diegeler, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <state>Hessen</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yeong-Hoon Choi, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Walther, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schüchtermann Klinik</name>
      <address>
        <city>Bad Rothenfelde</city>
        <state>Niedersachsen</state>
        <zip>49214</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicolas Doll, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel Wendt, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln (AöR)</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein Westfalen</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thorsten Wahlers, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Justus Strauch, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Payam Akhyari, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westphalen</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Farhad Bakhtiary, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Siegburg</name>
      <address>
        <city>Siegburg</city>
        <state>Nordrhein-Westphalen</state>
        <zip>53721</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Mirko Doss, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jörg Kempfert, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäres Herz- und Gefässzentrum UKE Hamburg GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lenard Conradi, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>European Hospital</name>
      <address>
        <city>Roma</city>
        <state>Lazio</state>
        <zip>700149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ruggero De Paulis, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick Klein, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

